NVRI vs VRTX · rev $511.4M vs P/E 30, rev $3.33B
Enviri Corporation (NVRI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Enviri Corporation (NVRI) is a waste management company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported NVRI revenue for 2026-06-30 was $511.4M. Net income was -$406.7M. Revenue was down 7.0% from 2026-03-31 to 2026-06-30. NVRI currently screens at market cap $553.8M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
NVRI currently screens at market cap $553.8M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the NVRI and VRTX stock pages for the full models.
Not investment advice.